Antihypertensive treatment in elderly hypertensives without a history of stroke and the risk of cognitive disorders

Acta Neurologica Scandinavica

Volumn 118, Issue 3, 2008, Pages 139-145

  Hadjiev, D I ^a,c   Mineva, P P ^b  

^a UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

^b TRAKIA UNIVERSITY   (Bulgaria)

^c NONE   (Bulgaria)

Author keywords

Cerebral hypoperfusion; Cognition; Hypertension; MRI abnormalities

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORTALIDONE; DIURETIC AGENT; ENALAPRIL; HYDROCHLOROTHIAZIDE; NITRENDIPINE; RESERPINE;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; BRAIN DAMAGE; BRAIN PERFUSION; CARDIOVASCULAR RISK; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CORRELATION ANALYSIS; ELDERLY CARE; FOLLOW UP; HUMAN; HYPERTENSION; MEDLINE; NEUROIMAGING; NEUROPHYSIOLOGICAL RECRUITMENT; PATHOGENESIS; PROSPECTIVE STUDY; REVIEW; STROKE; WHITE MATTER;

AGED; ANTIHYPERTENSIVE AGENTS; BRAIN; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; HUMANS; HYPERTENSION; RISK FACTORS; STROKE;

EID: 49649120192     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2008.01001.x     Document Type: Review

References (82)

1. Cacciatore F, Abete P, Ferrara N et al. The role of blood pressure in cognitive impairment in an elderly population. Osservatorio Geriatrico Campano Group. J Hypertens 1997 15 : 135 42.
2. Starr JM, Deary IJ, Inch S, Cross S, MacLennan WJ. Blood pressure and cognitive decline in healthy old people. J Hum Hypertens 1997 11 : 777 81.
3. Skoog I. Status of risk factors for vascular dementia. Neuroepidemiology 1998 17 : 2 9.
4. Harrington F, Saxby BK, McKeith IG, Wesnes K, Ford GA. Cognitive performance in hypertensive and normotensive older subjects. Hypertension 2000 36 : 1079 82.
5. Paglieri C, Bisbocci D, Amenta F, Veglio F. Arterial hypertension and cognitive deficit. Ann Ital Med Int 2004 19 : 163 70.
6. Kuo HK, Sorond F, Iloputaife I, Gagnon M, Milberg W, Lipsitz LA. Effect of blood pressure on cognitive functions in elderly persons. J Gerontol A Biol Sci Med Sci 2004 59 : 1191 4.
7. Roman GC. Vascular dementia. Advances in nosology, diagnosis, treatment and prevention. Panminerva Med 2004 46 : 207 15.
8. Skoog I, Lernfelt B, Landahl S et al. 15-year longituidal study of blood pressure and dementia. Lancet 1996 347 : 1141 5.
9. Guidelines Committee. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003 21 : 1011 53.
10. Chobanian AV, Bakris GL, Black HR et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003 42 : 1206 52.
11. Sacco RL, Adams R, Albers G et al. American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack. Stroke 2006 37 : 577 17.
12. Birns J, Markus H, Kalra L. Blood pressure reduction for vascular risk: is there a price to be paid? Stroke 2005 36 : 1308 13.
13. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001 358 : 1682 6.
14. Kety SS, Hafkenschiel JH, Jeffers WA, Leopold IH, Shenkin HA. The blood flow, vascular resistance, and oxygen consumption of the brain in essential hypertension. J Clin Invest 1948 27 : 511 14.
15. Barry DI. Cerebral blood flow in hypertension. J Cardiovasc Pharmacol 1985 7 (Suppl 2 S94 8.
16. Barry DI. Cerebrovascular aspects of antihypertensive treatment. Am J Cardiol 1989 63 : 14C 18C.
17. Meyer JS, Rogers RL, Mortel KF. Prospective analysis of long term control of mild hypertension on cerebral blood flow. Stroke 1985 16 : 985 90.
18. Rodriguez G, Arvigo F, Marenco S et al. Regional cerebral blood flow in essential hypertension: data evaluation by a mapping system. Stroke 1987 18 : 13 20.
19. Nobili F, Rodriguez G, Marenco S et al. Regional cerebral blood flow in chronic hypertension. A correlative study. Stroke 1993 24 : 1148 53.
20. Efimova IIu, Astanina IA, Kolodina MV. Cerebral microcirculation and structural changes in the brain in essential hypertension. Klin Med (Mosk) 2004 82 : 16 19.
21. Beason-Held LL, Moghekar A, Zonderman AB, Kraut MA, Resnick SM. Longitudinal changes in cerebral blood flow in the older hypertensive brain. Stroke 2007 38 : 1766 73.
22. Hadjiev D, Mineva P. Cerebral blood flow changes in elderly hypertensive patients and cognitive functions. Stroke 2007 (epub ahead of print).
23. Mentis MJ, Salerno J, Horwitz B et al. Reduction of functional neuronal connectivity in long-term treated hypertension. Stroke 1994 25 : 601 7.
24. Salerno JA, Grady C, Mentis M et al. Brain metabolic function in older men with chronic essential hypertension. J Gerontol A Biol Sci Med Sci 1995 50 : M147 54.
25. Sierra C, de la Sierra A, Chamorro A, Larrousse M, Domenech M, Coca A. Cerebral hemodynamics and silent cerebral white matter lesions in middle-aged essential hypertensive patients. Blood Press 2004 13 : 304 9.
26. Zhang P, Huang Y, Li Y, Lu M, Wu Y. A large-scale study on relationship between cerebral blood flow velocity and blood pressure in a natural population. J Hum Hypertens 2006 20 : 742 8.
27. Ruitenberg A, den Heijer T, Bakker SL et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol 2005 57 : 789 94.
28. Hougaku H, Matsumoto M, Kitagawa K et al. Silent cerebral infarction as a form of hypertensive target organ damage in the brain. Hypertension 1992 20 : 816 20.
29. Schmidt R, Fazekas F, Koch M et al. Magnetic resonance imaging cerebral abnormalities and neuropsychologic test performance in elderly hypertensive subjects. A case-control study. Arch Neurol 1995 52 : 905 10.
30. Strassburger TL, Lee HC, Daly EM et al. Interactive effects of age and hypertension on volumes of brain structures. Stroke 1997 28 : 1410 17.
31. O'Brien JT, Wiseman R, Burton EJ et al. Cognitive associations of subcortical white matter lesions in older people. Ann N Y Acad Sci 2002 977 : 436 44.
32. Schmidt R, Schmidt H, Fazekas F. Vascular risk factors in dementia. J Neurol 2000 247 : 81 7.
33. Havlik RJ, Foley DJ, Sayer B, Masaki K, White L, Launer LJ. Variability in midlife systolic blood pressure related to late-life brain white matter lesions: the Honolulu-Asia aging study. Stroke 2002 33 : 26 30.
34. Gomez-Angelats E, de La Sierra A, Sierra C, Parati G, Mancia G, Coca A. Blood pressure variability and silent cerebral damage in essential hypertension. Am J Hypertens 2004 17 : 696 700.
35. Heijer T, Skoog I, Oudkerk M et al. Association between blood pressure levels over time and brain atrophy in the elderly. Neurobiol Aging 2003 24 : 307 13.
36. van Dijk EJ, Breteler MM, Schmidt R et al. CASCADE Consortium. The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension 2004 44 : 625 30.
37. Wiseman RM, Saxby BK, Burton EJ, Barber R, Ford GA, O'Brien JT. Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects. Neurology 2004 63 : 1892 7.
38. Verghese J, Lipton RB, Hall CB, Kuslansky G, Katz MJ. Low blood pressure and the risk of dementia in very old individuals. Neurology 2003 61 : 1667 72.
39. Qiu C, von Strauss E, Fastbom J, Winblad B, Fratiglioni L. Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Arch Neurol 2003 60 : 223 8.
40. Qiu C, von Strauss E, Winblad B, Fratiglioni L. Decline in blood pressure over time and risk of dementia: a longitudinal study from the Kungsholmen project. Stroke 2004 35 : 1810 15.
41. Nilsson SE, Read S, Berg S, Johansson B, Melander A, Lindblad U. Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older. Aging Clin Exp Res 2007 19 : 41 7.
42. O'Brien JT, Erkinjuntti T, Reisberg B et al. Vascular cognitive impairment. Lancet Neurol 2003 2 : 89 98.
43. O'Brien JT. Vascular cognitive impairment. Am J Geriatr Psychiatry 2006 14 : 724 33.
44. Kannel WB. Influence of multiple risk factors on the hazard of hypertension. J Cardiovasc Pharmacol 1990 16 (Suppl 5 S53 7.
45. Kannel WB. Risk stratification in hypertension: new insights from the Framingham Study. Am J Hypertens 2000 13 : 3S 10S.
46. Stegmayr B, Asplund K, Kuulasmaa K, Rajakangas AM, Thorvaldsen P, Tuomilehto J. Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project. An ecological study of 18 populations. Stroke 1997 28 : 1367 74.
47. Hadjiev D. Epidemiology of stroke. In : Bergen DS, Chopra JS, Silberberg D, Barac B, Lechner H, eds. Progress in neurology - II. New Delhi : BI Churchill Livingstone Pvt Ltd, 1998 66 71.
48. Foucan L, Bangou-Bredent J, Ekouevi DK, Deloumeaux J, Roset JE, Kangambega P. Hypertension and combinations of cardiovascular risk factors. An epidemiologic case control study in an adult population in Guadeloupe (FWI). Eur J Epidemiol 2001 17 : 1089 95.
49. Hadjiev DI, Mineva PP, Vukov MI. Multiple modifiable risk factors for first ischemic stroke: a population-based epidemiological study. Eur J Neurol 2003 10 : 577 82.
50. Schmidt R, Fazekas F, Kleinert G et al. Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers. Arch Neurol 1992 49 : 825 7.
51. Posner HB, Tang MX, Luchsinger J, Lantigua R, Stern Y, Mayeux R. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 2002 58 : 1175 81.
52. O'Leary DH, Polak JF, Kronmal RA et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke 1992 23 : 1752 60.
53. Fine-Edelstein JS, Wolf PA, O'Leary DH et al. Precursors of extracranial carotid atherosclerosis in the Framingham Study. Neurology 1994 44 : 1046 50.
54. Mannami T, Konishi M, Baba S, Nishi N, Terao A. Prevalence of asymptomatic carotid atherosclerosis lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita Study. Stroke 1997 28 : 518 25.
55. Peter WF, Wilson MD, Jeffrey M et al. Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. N Engl J Med 1997 337 : 516 22.
56. Rao R. The role of carotid stenosis in vascular cognitive impairment. J Neurol Sci 2002 204 : 103 7.
57. Johnston SC, O'Meara ES, Manolio TA et al. Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med 2004 140 : 237 47.
58. Mathiesen EB, Waterloo K, Joakimsen O, Bakke SJ, Jacobsen EA, Bonaa KH. Reduced neuropsychological test performance in asymptomatic carotid stenosis: the Tromso Study. Neurology 2004 62 : 695 701.
59. Bowler JV, Gorelick PB. Advances in vascular cognitive impairment 2006. Stroke 2007 38 : 241 4.
60. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991 265 : 3255 64.
61. Prince MJ, Bird AS, Blizard RA, Mann AH. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the medical research council's trial of hypertension in older adults. BMJ 1996 30 : 801 5.
62. Forette F, Seux ML, Staessen JA et al. Prevention of dementia in randomized double-blind placebo-controlled systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998 352 : 1347 51.
63. in't Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM. Antihypertensive drugs and incidince of dementia: the Rotterdam study. Neurobiol Aging 2001 22 : 407 12.
64. Peila R, White LR, Masaki K, Petrovitch H, Launer LJ. Reducing the risk of dementia: efficacy of long-term treatment of hypertension. Stroke 2006 37 : 1165 70.
65. Brust JC. Antihypertensive therapy and cognition: more questions than answers. Stroke 2006 37 : 1146.
66. Shah RC, Wilson RS, Bienias JL, Arvanitakis Z, Evans DA, Bennett DA. Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons. Neuroepidemiology 2006 26 : 30 6.
67. Feigin V, Ratnasabapathy Y, Anderson C. Does blood pressure lowering treatment prevents dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease? J Neurol Sci 2005 230 : 151 5.
68. McGuinness B, Todd S, Passmore P, Bullock R. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database Syst Rev 2006 2 : CD004034.
69. Liao D, Cooper L, Cai J et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke 1996 27 : 2262 70.
70. Dufouil C, de Kersaint-Gilly A, Besancon V et al. Longituidal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology 2001 56 : 921 6.
71. de Leeuw FE, de Groot JC, Oudkerk M et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 2002 125 (Pt 4 765 72.
72. Hadjiev D, Mineva P. Antihypertensive treatment in reducing the risk of dementia. Stroke 2006 37 : 2869.
73. Meyer JS, Judd BW, Tawakina T, Rogers RL, Mortel KF. Improved cognition after control of risk factors for multiinfarct dementia. JAMA 1986 256 : 2203 9.
74. Ruitenberg A, Skoog I, Ott A et al. Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord 2001 12 : 33 9.
75. Pandav R, Dodge HH, DeKosky ST, Ganguli M. Blood pressure and cognitive impairment in India and the United States: a cross-national epidemiological study. Arch Neurol 2003 60 : 1123 8.
76. Roman GC. Vascular dementia prevention: a risk factor analysis. Cerebrovasc Dis 2005 20 (Suppl 2 91 100.
77. Robinson JG, Bakris G, Torner J, Stone NJ, Wallace R. Is it time for a cardiovascular primary prevention trial in the elderly? Stroke 2007 38 : 441 50.
78. Scheid R, Voigt H. Arterial hypertension and dementia. Nervenarzt 2005 76 : 143 53.
79. Hack W, Kaste M, Bogousslavsky J et al. The European Stroke Initiative Executive Committee and the EUSI Writing Committee. European stroke initiative recommendations for stroke management - update 2003. Cerebrovasc Dis 2003 16 : 311 37.
80. Schrader J, Luders S, Kulschewski A et al. for the MOSES Study Group. Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES). Stroke 2005 36 : 1218 26.
81. Peters R, Beckett N, Nunes M, Fletcher A, Forette F, Bulpitt C. A substudy protocol of the hypertension in the very elderly trial assessing cognitive decline and dementia incidence (HYVET-COG): an ongoing randomised, double-blind, placebo-controlled trial. Drugs Aging 2006 23 : 83 92.
82. Hachinski V, Iadecola C, Petersen RC et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006 37 : 2220 41.